Confirmed indication
The hematology team should explain why transplant is being considered, what alternatives exist, and what response is required before admission.
Bone marrow transplant in India
Best Hospitals for Bone Marrow Transplant in India
A practical comparison route for families assessing adult or pediatric BMT programmes, cell processing, donor options, isolation, ICU support, and follow-up after discharge.
What should a BMT hospital be able to show?
Look for a programme that can explain the disease indication, confirm the transplant type, document current authorization or accreditation where applicable, provide controlled cell processing and infection-safe care, and continue monitoring after the patient returns home.
Share your treatment records
Get a hospital shortlist matched to the patient’s case.
A report-led review helps the care team compare procedure fit, hospital capability, city, timing, and travel needs before an enquiry is sent.
Official email: support@virellohealth.com
Let Us Help You
Share the basics and the Virello team will guide you toward the next step.
Prefer email? Write to support@virellohealth.com.
Shortlist decision
How to choose the right hospital path
Programme authorization
Ask for the hospital registration or authorization relevant to the planned service and verify it against the current official register.
Cell source and processing
Confirm collection, cryopreservation or fresh-cell handling, laboratory release, traceability, and contingency plans.
Infection control
Compare HEPA or protective rooms where used, isolation policy, fever response, antimicrobial support, blood products, and 24-hour access.
Donor pathway
For allogeneic care, ask about HLA testing, donor search, related or unrelated donors, conditioning, and graft-versus-host prevention.
Long-term handover
A reliable programme should provide a transplant summary, medicine list, warning signs, vaccination advice, and a named follow-up contact.
Hospitals patients often compare
Use hospital names as a starting point, then verify case fit.
The examples below are not a fixed ranking. They show how families can discuss hospital types, city routes, and department strengths before a report-led shortlist is prepared.
Kolkata
Tata Medical Center
Cancer-focused programme with adult and pediatric hematology and cellular therapy services listed by FACT.
It may be relevant for families seeking a dedicated cancer environment with documented cellular therapy scope.
Verify the current accreditation entry, age group, transplant type, appointment process, and availability at the treating campus.
Evidence check
Campus reviewed: Tata Medical Center, Kolkata. Source review: 2026-08-01.
Availability and credentials can change. Confirm the exact programme, treating team, and current case acceptance before booking.
Bengaluru
Ramaiah Memorial Hospital
FACT-listed hematopoietic progenitor cell programme covering adult and pediatric autologous and allogeneic pathways.
The published programme scope gives families a concrete starting point for an evidence-led cellular therapy comparison.
Confirm the current scope, cell-processing arrangements, consultant availability, and admission timeline before travel.
Evidence check
Campus reviewed: Ramaiah Memorial Hospital, Bengaluru. Source review: 2026-08-01.
Availability and credentials can change. Confirm the exact programme, treating team, and current case acceptance before booking.
Chennai
Apollo Cancer Centre
Private cancer route with hematology, transplant evaluation, laboratory, transfusion, infection, and critical-care support.
Chennai can suit families looking for a large private oncology ecosystem and international patient coordination.
Ask for disease-specific eligibility, donor or cell-source steps, isolation plan, and a phase-wise estimate.
Evidence check
Campus reviewed: Apollo Cancer Centre, Chennai. Source review: 2026-08-01.
Availability and credentials can change. Confirm the exact programme, treating team, and current case acceptance before booking.
New Delhi
BLK-Max Super Speciality Hospital
Private tertiary route with hematology, BMT, cell processing, transfusion, critical care, and supportive departments.
New Delhi offers a private transplant route with access to a broad oncology and intensive-care network.
Verify current transplant type, programme authorization, infection facilities, and after-hours hematology access.
Evidence check
Campus reviewed: BLK-Max Super Speciality Hospital, New Delhi. Source review: 2026-08-01.
Availability and credentials can change. Confirm the exact programme, treating team, and current case acceptance before booking.
Gurugram
Medanta - The Medicity
Multispecialty hematology and transplant pathway with laboratory, ICU, infectious disease, and organ support.
A multispecialty campus may help when BMT is complicated by kidney, heart, infection, or other medical issues.
Request the named transplant physician, cell pathway, admission duration, and plan for complications.
Evidence check
Campus reviewed: Medanta - The Medicity, Gurugram. Source review: 2026-08-01.
Availability and credentials can change. Confirm the exact programme, treating team, and current case acceptance before booking.
Bengaluru
HCG Cancer Centre
Cancer network with hematology, transplant evaluation, laboratory, oncology, and supportive treatment services.
Bengaluru is an option for families comparing private cancer care and longer recovery arrangements.
Confirm which branch provides transplant, cell processing, pediatric support, and ICU coverage.
Evidence check
Campus reviewed: HCG Cancer Centre, Bengaluru. Source review: 2026-08-01.
Availability and credentials can change. Confirm the exact programme, treating team, and current case acceptance before booking.
Vellore
CMC Vellore
Academic tertiary-care route with hematology, pediatric services, laboratory, transplant, and complex medical support.
An academic pathway may be useful for difficult diagnoses, second opinions, or protocol-led treatment review.
Check referral requirements, waiting time, patient age criteria, lodging, and current programme availability.
Evidence check
Campus reviewed: CMC Vellore, Vellore. Source review: 2026-08-01.
Availability and credentials can change. Confirm the exact programme, treating team, and current case acceptance before booking.
Kochi
Aster Medcity
Tertiary hospital option with hematology, oncology, transplant assessment, infection, ICU, and recovery support.
Kochi may suit selected stable cases when the full programme and emergency support are confirmed.
Do not book travel for an unstable patient without the treating hematologist clearance.
Evidence check
Campus reviewed: Aster Medcity, Kochi. Source review: 2026-08-01.
Availability and credentials can change. Confirm the exact programme, treating team, and current case acceptance before booking.
Cancer-specific care pathway
How the team moves from diagnosis to follow-up
The right hospital should be able to coordinate the tests, pathology review, treatment decisions, and recovery support that match this cancer type and the patient’s current condition.
BMT diagnosis and eligibility
The hospital should establish the disease, response, and fitness before discussing a transplant date.
Disease confirmation
Blood counts, marrow examination, flow cytometry, cytogenetics, molecular tests, imaging, or pathology may be needed according to the condition.
Response assessment
The team checks remission, measurable residual disease, scan response, or other markers before deciding whether transplant is appropriate.
Fitness review
Heart, lung, kidney, liver, infection, dental, nutrition, fertility, and psychosocial assessments help estimate transplant readiness.
Transplant consultation
The doctor should explain transplant intent, alternatives, expected admission, major risks, and how the decision may change with new results.
BMT risk and donor assessment
BMT does not use one universal cancer stage; disease risk, response, donor, and patient factors shape the pathway.
Disease risk
Subtype, genetic findings, prior treatment, relapse status, remission depth, and MRD can affect transplant timing and expected risk.
HLA and donor route
For allogeneic transplant, the team may assess related, unrelated, haploidentical, or cord blood options and explain matching limits.
Organ and infection risk
The team considers prior chemotherapy, active infection, organ function, frailty, nutrition, and the ability to tolerate conditioning.
Family readiness
Caregiver availability, accommodation near the hospital, finances, language, and emergency access matter during prolonged recovery.
Bone marrow transplant treatment plan
A complete plan covers preparation, cell administration, engraftment, complications, and the first months after discharge.
Conditioning
Chemotherapy with or without radiation prepares the body for the planned transplant and depends on disease, donor, and patient fitness.
Cell collection and infusion
Cells may be collected from marrow or blood, processed and tracked, then infused through a central line under close monitoring.
Engraftment support
Transfusions, antimicrobial medicines, nutrition, mucositis care, fever evaluation, and organ monitoring continue while counts recover.
Complication planning
Ask about graft-versus-host disease, relapse, graft failure, bleeding, viral reactivation, kidney or lung effects, and ICU escalation.
BMT long-term follow-up
The first discharge is not the end of transplant care; monitoring may continue for months or years.
Engraftment and disease checks
CBC, marrow or molecular testing, MRD, imaging, and chimerism may be scheduled according to the disease and transplant type.
Infection and vaccines
The team explains fever thresholds, prophylaxis, visitor precautions, vaccination timing, and when immune recovery changes risk.
Graft-versus-host review
Allogeneic recipients need monitoring of skin, mouth, eyes, gut, liver, lungs, joints, and other possible chronic effects.
Home handover
Leave with a transplant summary, medicines, line care, diet guidance, emergency number, travel advice, and remote review schedule.
Selection criteria
What to compare before choosing a hospital
Current programme status
Is the exact campus authorized or appropriately accredited for the planned BMT type and patient age?
Do not rely on a hospital network claim.
Cell processing
Can the programme collect, process, store, release, and trace cells under documented quality controls?
Ask where processing occurs.
Infection safety
Are isolation, HEPA or protective rooms where needed, antimicrobial support, and fever response available?
Confirm 24-hour access.
Transfusion and ICU
Can the hospital provide blood products, renal support, ventilation, and critical care during complications?
Ask about backup at the same campus.
Donor support
For allogeneic cases, who manages HLA, donor search, collection, and donor follow-up?
Donor and recipient care should both be documented.
Continuity
Will the hospital issue a detailed discharge and long-term follow-up plan for the home doctor?
This is essential for international patients.
Treatment fit
Match hospital strength to the treatment pathway
The same hospital can be strong in several areas, but each patient still needs matching by diagnosis, procedure, risk, and recovery needs.
Cellular therapy infrastructure
The transplant unit should connect laboratory controls with bedside care.
Collection and traceability
Ask how cell identity, storage, transport, release, and contingency procedures are documented.
Protective care
Compare isolation, transfusion, antimicrobial, nutrition, line, and emergency services rather than a room label alone.
Recovery and survivorship
Families need a clear plan for the months after discharge.
Complication response
Ask who reviews fever, rash, diarrhea, breathing symptoms, bleeding, or medicine toxicity after discharge.
Long-term monitoring
Confirm plans for relapse, MRD, graft-versus-host disease, fertility, endocrine health, bone health, and vaccines.
City strategy
Compare Tier 1 depth with Tier 2 value
Bengaluru and Kolkata
Offer documented cellular-therapy options to compare alongside other transplant centres.
Verify the current accreditation scope and patient age.
Delhi NCR
Provides private and academic hematology routes with broad critical-care support.
Compare programme authorization, donor pathway, and accommodation.
Chennai
Offers major private oncology and transplant infrastructure.
Request an admission and infection-control calendar.
Hyderabad and Kochi
Can be considered where the exact transplant service and emergency support are confirmed.
Check whether cell processing and ICU are on-site.
Vellore and other cities
Academic or value routes may suit selected complex evaluations.
Do not choose solely on quoted package price.
Reports before matching
What to share before asking for a shortlist
Reports help the hospital and doctor team understand whether the patient needs a complex metro route, a specialty center, or a stable planned-care option.
- 1 Diagnosis, marrow, pathology, flow, cytogenetic, molecular, MRD, imaging, and response reports.
- 2 Prior chemotherapy, radiation, transplant consultations, admission summaries, transfusion history, and infection records.
- 3 Heart, lung, kidney, liver, dental, fertility, nutrition, vaccination, and medication assessments.
- 4 HLA typing, donor search, related donor records, cell collection, and processing documents when applicable.
- 5 Current symptoms, allergies, fever history, central line information, and emergency contact details.
- 6 Passport or identity documents, caregiver details, and records needed for hospital or visa review.
Cost and stay planning
What can change total treatment cost
Pre-transplant workup
Marrow, molecular, HLA, infection, imaging, organ, dental, fertility, and nutrition tests may be separate.
Ask which tests can be accepted from home.
Conditioning and admission
Regimen, isolation, transfusion, medicines, ICU, complications, and engraftment time change the estimate.
Ask how unexpected admission days are billed.
Cell processing
Collection, apheresis, cryopreservation, laboratory processing, storage, and release may be separate cost lines.
Confirm whether processing is in-house.
Post-discharge medicines
Antimicrobials, immunosuppression, growth factors, transfusions, and monitoring may continue for months.
Ask for a phase-wise home estimate.
Caregiver stay
The patient may need a nearby room, attendant, food precautions, transport, and frequent reviews after discharge.
Plan for a longer local stay.
International patient support
Support that should be planned with hospital choice
Record triage
A coordinator can organize the marrow, response, HLA, infection, and prior treatment records before the specialist review.
Donor documentation
Families can receive a checklist for HLA records, donor identity, consent, travel, and hospital requirements.
Protective accommodation
Plan a nearby stay, safe transport, food arrangements, visitor limits, and access to urgent review.
Treatment calendar
A dated calendar should show evaluation, conditioning, infusion, expected engraftment, discharge, and early follow-up.
Language and consent
Interpretation should cover conditioning, transfusion, infection, graft-versus-host disease, and emergency signs.
Return-home handover
The final packet should include treatment summary, medicines, laboratory schedule, vaccines, and local doctor instructions.
Safety checks
Red flags to review before booking travel
Unverified programme
Do not rely on a generic BMT listing without confirming the exact campus, current status, and transplant type.
Fever or bleeding
Fever, bleeding, severe breathlessness, confusion, or dehydration needs urgent medical assessment, not routine travel planning.
Guaranteed results
Outcomes depend on disease, response, age, donor, conditioning, complications, and follow-up; guarantees are not appropriate.
Short package only
A quote that omits isolation, transfusions, ICU, cell processing, medicines, and post-discharge reviews is incomplete.
Sources and review
Check the evidence behind this guide
Hospital availability, accreditation, authorization, and treatment claims can change. Confirm the current campus details with the hospital before travel or admission.
FACT India cellular therapy directory FACT cellular therapy standards and scope National Cancer Grid NABH healthcare organisation directory WHO transplantation principles
Transplant pathway reviewed for page planning on 30 July 2026. Programme authorization, accreditation scope, hospital capacity, donor services, prices, and consultant availability must be verified before publication or travel.
Questions
Common questions
How do I compare the best bone marrow transplant hospitals in India?
Compare diagnosis and response review, transplant type, cell processing, donor services, infection control, transfusion and ICU support, authorization, and long-term follow-up.
Is bone marrow transplant the same as stem cell transplant?
Bone marrow transplant is often used as a broad term, but hematopoietic cells may come from marrow, peripheral blood, or cord blood. Ask the hospital to name the exact source and procedure.
How long is hospital admission for BMT?
The stay depends on conditioning, engraftment, infection, organ function, and complications. The hospital should provide a patient-specific range rather than a guaranteed duration.
What accreditation should a BMT family check?
Check the relevant national authorization and, where applicable, current cellular-therapy accreditation and scope. Confirm the entry matches the campus, patient age, and transplant type.
Can international patients receive BMT in India?
Some hospitals accept international patients, but eligibility, urgent care, visa documents, donor arrangements, and local follow-up must be confirmed before travel.
What is the difference between autologous and allogeneic BMT?
Autologous transplant uses the patient cells. Allogeneic transplant uses donor cells and adds matching, graft-versus-host, donor, and immune-recovery considerations.
What happens after returning home?
The patient needs blood or marrow monitoring, medicine management, infection precautions, vaccination planning, and a clear route back to the transplant team.
Can Virello Health shortlist a BMT hospital?
Virello Health can organize records and verified hospital enquiries. The hematology and transplant team decides whether transplantation is appropriate.
Continue planning
Move from hospital research to a report-led shortlist
Leukemia treatment hospitals
Compare the blood cancer pathway before transplant.
Autologous transplant hospitals
Review patient-cell transplant options.
Allogeneic transplant hospitals
Review donor-cell transplant options.
BMT treatment cost
Understand admission and follow-up variables.
Hematology doctors
Request a specialist review.
Upload transplant reports
Share marrow, donor, and treatment records.
Second opinion
Ask for another transplant review.
Hospitals by procedure
Compare other hospital pages.
Patient services
Plan travel and long-term support.